The oral glucose tolerance test. Role in the assessment of insulin secretion, insulin clearance and insulin action, and counterregulatory hormones;L'hyperglycémie provoquée par voie orale. Étude de la sécrétion de la clairance et de l'action de l'insuline, et du rétrocontrôle par les hormones de la contre-régulation

Immuno-Analyse et Biologie Specialisee

Volumn 18, Issue 4, 2003, Pages 185-190

  Luyckx, F H ^a   Scheen, A J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Acromegaly; Diabetes mellitus; Impaired glucose tolerance; Insulin; Oral glucose tolerance test

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ACROMEGALY; DIABETES MELLITUS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONAL REGULATION; HORMONE METABOLISM; HORMONE SENSITIVITY; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MEDICAL ASSESSMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; STEADY STATE;

EID: 1242341268     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(03)00064-4     Document Type: Review

References (56)

1. Ahren B., Larsson H. Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women. Diabetes. 51:(Suppl 1):2002;S202-S211.
2. Albareda M., Rodriguez-Espinosa J., Murugo M., de Leiva A., Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia. 43:2000;1507-1511.
3. Avignon A., Boegner C., Mariano-Goulart D., Collette C., Monnier L. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes. 23:1999;512-517.
4. Belfiore F., Iannello S., Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab. 63:1998;134-141.
5. Bergman R.N., Finegood D.T., Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 6:1985;45-86.
6. Bergman R.N. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 38:1989;1512-1527.
7. Breda E., Cavaghan M.K., Toffolo G., Polonsky K.S., Cobelli C. Oral glucose tolerance test minimal model indexes of B-cell function and insulin sensitivity. Diabetes. 50:2001;150-158.
8. Cagnacci A., Arangino S., Renzi A., Cagnacci P., Volpe A. Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting. Eur J Endocrinol. 145:2001;281-287.
9. Castillo M.J., Scheen A.J., Letiexhe M.R., Lefèbvre P.J. How to measure insulin clearance. Diabetes/Metab Rev. 10:1994;119-150.
10. Cederholm J., Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract. 10:1990;167-175.
11. Cervenakova Z., Ksinantova L., Koska J. Effect of body composition on indices of insulin sensitivity and beta-cell function in healthy men. Endocr Regul. 36:2002;73-77.
12. Cretti A., Lehtovirta M., Bobora E., et al. Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest. 31:2001;405-416.
13. De Marinis L., Mancini A., Bianchi A., et al. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. Metabolism. 51:2002;616-621.
14. Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology. 122:2002;531-544.
15. Fernandez-Real J.-M., Ricart W., Casamitjana R. Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity. Clin Endocrinol. 47:1997;583-588.
16. Giustina A., Barkan A., Casanueva F.F., et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab. 85:2000;526-529.
17. Gutt M., Davis C.L., Spitzer S.B., Llabre M.M., Kumar M., Czarnecki E.M., et al. Validation of the insulin sensitivity index: comparison with other measures. Diabetes Res Clin Pract. 47:2000;177-184.
18. Haffner S.M., Miettinen H., Gaskill S.P., Stern M.P. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia. 39:1996;1201-1207.
19. Hanson R.L., Pratley R.E., Bogardus C., et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiological studies. Am J Epidemiol. 151:2000;190-198.
20. Himsworth H.P. Diabetes mellitus. Its differentiation into insulin-sensitive and insulin-insensitive types. Lancet. 1:(part 1):1936;127-130.
21. Kanauchi M., Akai Y., Hashimoto T. Validation of simple indices to assess insulin sensitivity and pancreatic Beta-cell function in patients with renal dysfunction. Nephron. 92:2002;713-715.
22. Lefèbvre P.J., Scheen A.J. Glucose metabolism and the postprandial state. Eur J Clin Invest. 29:1999;1-6.
23. Luyckx A., Lefèbvre P. Évidence d'une réduction de la sécrétion d'insuline dans le diabète avec ou sans obésité. Discussion de l'emploi thérapeutique des biguanides. Ann Endocrinol (Paris). 30:1969;717-730.
24. Luyckx F.H., Scheen A.J. Comment j'explore. les anomalies du métabolisme glucidique, de l'insulinosécrétion et de la sensibilité à l'insuline avec une hyperglycémie provoquée par voie orale. Rev Med Liège. 56:2001;881-885.
25. Luyckx F.H., Scheen A.J. L'hyperglycémie provoquée par voie orale. 1. De la controverse à un plaidoyer pour sa place en biologie clinique. Immuno-Anal Biol Spec. 18:2003;185-190.
26. Malaisse W.J., Schöller Y. Mathematical modeling of changes in circulating insulin and C-peptide concentrations. Acta Diabet Lat. 22:1985;127-137.
27. Mari A. Mathematical modeling in glucose metabolism and insulin secretion. Curr Opin Clin Nutr Metab Care. 5:2002;495-501.
28. Mari A., Pacini G., Murphy E., Ludvik B., Nolan J.J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 24:2001;539-548.
29. Mari A., Schmitz O., Gastaldelli A., Oestergaard T., Nyholm B., Ferrannini E. Meal and oral tolerance tests for assessment of B-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab. 283:2002;E1159-E1166.
30. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care. 22:1999;1462-1470.
31. Melchionda N., Forlani G., Marchesini G., Baraldi L., Natale S. WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance. Int J Obesity. 26:2002;90-96.
32. Mitrakou A., Kelley D., Mokan M., et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J M. 326:1992;22-29.
33. Phillips D.I.W., Clark P.M., Hales C.N., Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic M. 11:1994;286-292.
34. Polonsky K., Frank B., Pugh W., et al. The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes. 35:1986;379-386.
35. Polonsky K.S., Rubenstein A.H. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pittfalls and limitations. Diabetes. 33:1984;486-494.
36. Rabasa-Lhoret R., Laville M. Mesurer l'insulinosensibilité en pratique clinique. Diabetes Metab. 27:2001;201-208.
37. Scheen A.J. Comment apprécier chez l'homme l'action de l'insuline en recherche et en pratique ? Ann Endocrinol (Paris). 60:1999;179-187.
38. Scheen A.J., Castillo M.J., Paquot N., Lefèbvre P.J. How to measure insulin action in vivo? Diabetes Metab Rev. 10:1994;151-188.
39. Scheen A.J., Lefèbvre P.J. Insulin resistance versus insulin deficiency: which one comes first? The old question revisited. Di Mario U., Leonetti F., Pugliese G., Sbraccia P., Signore A. Diabetes in the New Millennium. 2000;101-113 Wiley & Sons, New York.
40. Scheen A.J., Paquot N., Letiexhe M.R., Castillo M.J., Lefèbvre P.J. Comment évaluer la sécrétion insulinique en pratique ? Diabetes Metab. 21:1995;458-464.
41. Scheen A.J., Paquot N., Letiexhe M., et al. Glucose metabolism in obese subjects: lessons from OGTT, IVGTT, and clamp studies. Int J Obesity. 19:(Suppl 3):1995;S14-S20.
42. Seltzer H.S., Allen E.W., Herron A.R., Brennan M.T. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest. 46:1967;323-335.
43. Serri O., Somma M., Comtois R., et al. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy. J Clin Endocrinol Metab. 61:1985;1185-1189.
44. Shah P., Vella A., Basu A., et al. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 85:2000;4053-4059.
45. Shapiro E.T., Tillil H., Miler A., et al. Insulin secretion and clearance. Comparison after oral and intravenous glucose. Diabetes. 36:1987;1365-1371.
46. Sluiter W.J., Erkelens D.W., Reitsma W.D., Doorenbos H. Glucose tolerance and insulin release, a mathematical approach. I. Assay of the B-cell response after oral glucose loading. Diabetes. 25:1976;241-244.
47. Sluiter W.J., Erkelens D.W., Terpstra P., Reitsma W.D., Doorenbos H. Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes. 25:1976;245-249.
48. Stewart P.M., Smith S., Seth J., et al. Normal growth hormone response to the 75 g oral glucose tolerance test measured by immunoradiometric assay. Ann Clin Biochem. 26:1989;205-206.
49. Stumvoll M., Fritsche A., Häring H. The OGTT as test for beta cell function? Eur J Clin Invest. 31:2001;380-381.
50. Stumvoll M., Gerich J. Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes. Clin Lab M. 21:2001;31-51.
51. Stumvoll M., Mitrakou A., Pimenta W., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 23:2000;295-301.
52. Stumvoll M., Van Haeften T., Fritsche A., Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care. 24:2001;796-797.
53. Taniguchi A., Nagasaka S., Fukushima M., et al. Assessment of insulin sensitivity and insulin secretion from the oral glucose tolerance test in nonobese Japanese type 2 diabetic patients: comparison with minimal-model approach. Diabetes Care. 23:2000;1439-1440.
54. Thomaseth K., Kautzky-Willer A., Ludvik B., Prager R., Pacini G. Integrated mathematical model to asess B-cell activity during the oral glucose tolerance test. Am J Physiol. 270:1996;E522-E531.
55. Tillil H., Shapiro E.T., Miller M.A., et al. Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. Am J Physiol. 254:1988;E349-E357.
56. Valcavi R. Oral glucose tolerance test: an inhibitory or a stimulatory input to growth hormone secretion? J Endocrinol Invest. 19:1996;253-255.